Paper · 12200067

Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases.

McGuirk P and 1 other. Trends Immunol, 2002. Cited by 255 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Cite this record

ConductScience Library. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Papers, record 12200067. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/12200067

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title: Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases.; PubMed
Journal: Trends Immunol; PubMed
Year: 2002; PubMed
Publication types: Journal Article, Research Support, Non-U.S. Gov't, Review; PubMed
PubMed: https://pubmed.ncbi.nlm.nih.gov/12200067/; PubMed
DOI: https://doi.org/10.1016/s1471-4906(02)02288-3; PubMed
The journal: https://conductscience.org/library/journal-index/100966032; PubMed
Citations, by iCite: 255; iCite
Relative citation ratio, by iCite: 5.24; iCite
Revised in PubMed: 2022-03-11; PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Order	Author	Forename	Kind	ORCID iD
1	McGuirk P	Peter
2	Mills KH	Kingston H G

Source PubMed

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH term	Major
Communicable Diseases	Major topic
Receptors, Antigen, T-Cell	Major topic
Th1 Cells	Major topic
Th2 Cells	Major topic
Animals
Cell Differentiation
Humans
Immune Tolerance
Interleukin-10
Transforming Growth Factor beta

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by86

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 255 citations.

PMID	Title	Journal	Year	In Papers	Source
40,724,876	Autistic Traits in Schizophrenia: Immune Mechanisms and Inflammatory Biomarkers.	Int J Mol Sci	2025	https://conductscience.org/library/papers/40724876	PubMed
37,766,141	Sending a Message: Use of mRNA Vaccines to Target the Tumor Immune Microenvironment.	Vaccines (Basel)	2023	https://conductscience.org/library/papers/37766141	PubMed
37,679,744	The evolution and heterogeneity of neutrophils in cancers: origins, subsets, functions, orchestrations and clinical applications.	Mol Cancer	2023	https://conductscience.org/library/papers/37679744	PubMed
37,447,345	Dietary Plant Polysaccharides for Cancer Prevention: Role of Immune Cells and Gut Microbiota, Challenges and Perspectives.	Nutrients	2023	https://conductscience.org/library/papers/37447345	PubMed
36,785,674	Identification of a Five Immune Term Signature for Prognosis and Therapy Options (Immunotherapy versus Targeted Therapy) for Patients with Hepatocellular Carcinoma.	Comput Math Methods Med	2023	https://conductscience.org/library/papers/36785674	PubMed
36,420,056	Natural blood plasma-based hydrogels as tumor vaccines delivery systems to enhance biomimetic recruitment of antigen presenting cells for tumor immunotherapy.	Mater Today Bio	2022	https://conductscience.org/library/papers/36420056	PubMed
36,204,377	Benefits of neutral polysaccharide from rhizomes of Polygonatum sibiricum to intestinal function of aged mice.	Front Nutr	2022	https://conductscience.org/library/papers/36204377	PubMed
36,091,059	Immunomodulatory effects of the Bifidobacterium longum BL-10 on lipopolysaccharide-induced intestinal mucosal immune injury.	Front Immunol	2022	https://conductscience.org/library/papers/36091059	PubMed
34,957,113	Exosomal circRNAs: Emerging Players in Tumor Metastasis.	Front Cell Dev Biol	2021	https://conductscience.org/library/papers/34957113	PubMed
33,329,545	Impact of Helminth Infections on Female Reproductive Health and Associated Diseases.	Front Immunol	2020	https://conductscience.org/library/papers/33329545	PubMed

1 to 10 of 86

See all 86 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed: 2026-11-06; PubMed
iCite: 2026-11-05; iCite
PMC's ID file: 2026-11-05; PMC's ID file
NIH RePORTER's grant and paper links: 2026-11-01; NIH RePORTER's grant and paper links
Trials: 2026-11-12
Gene search: 2026-11-11
Pipelines: 2026-09-18

Sources 11

ChEMBL, through Open TargetsCC BY-SA 3.0
ClinicalTrials.govNo license stated
HGNCCC0
iCiteCC BY 4.0
NCBI GenePublic domain (US government)
NIH RePORTER's grant and paper linksPublic domain
Open TargetsCC0 1.0
PMC's ID filePublic domain (US government)
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0

Each source's terms

ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
ClinicalTrials.govnone stated
HGNCCC0: https://www.genenames.org/about/license/
iCiteCC BY 4.0
NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
PubMedNLM's terms
PubTator 3Public domain
UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/12200067

GET https://conductscience.org/api/papers/v1/12200067/cited_by?page=2

API reference For AI assistants